MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
The Lancet Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

832 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
832 works in the cohort · of 4,299,418page 7 of 17

Labels cover 9 of 832 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 832 of 832 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker +46 more
2021· article· en· The Lancet Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
175
citations
affno abstractunlabeled
Trastuzumab: hopes and realities
Brian Leyland‐Jones
2002· review· en· The Lancet Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
169
citations
affno abstractunlabeled
Antisense therapy for cancer—the time of truth
Burkhard Jansen, Uwe Zangemeister‐Wittke
2002· review· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
168
citations
fundno affno abstractunlabeled
Impact of COVID-19 on cancer care in India: a cohort study
Priya Ranganathan, Manju Sengar, Girish Chinnaswamy, Gaurav Agrawal, Rajkumar Arumugham, Rajiv Bhatt +38 more
2021· article· en· The Lancet Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
164
citations
affno abstractunlabeled
Oncology nursing workforce: challenges, solutions, and future strategies
Julia Challinor, Mohammad R. Alqudimat, Tamara Otsuru Augustinho Teixeira, Wendy H. Oldenmenger
2020· review· en· The Lancet Oncology· Health Professions
distilled prediction:candidate · metaepi_narrow+sts+research_integrityconsensus · research_integrity
155
citations
affno abstractunlabeled
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial
Lee S. Schwartzberg, Manuel Modiano, Bernardo L. Rapoport, Martin Chasen, Cesare Gridelli, László Urbán +4 more
2015· article· en· The Lancet Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
151
citations
affno abstractunlabeled
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium
Eva Clemens, Marry M. van den Heuvel‐Eibrink, Renée L. Mulder, Leontien C.M. Kremer, Melissa M. Hudson, Roderick Skinner +25 more
2019· review· en· The Lancet Oncology· Neuroscience
distilled prediction:candidate · noneconsensus · none
143
citations
affno abstractunlabeled
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials
Bernardo L. Rapoport, Martin Chasen, Cesare Gridelli, László Urbán, Manuel Modiano, Ian D. Schnadig +5 more
2015· article· en· The Lancet Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
141
citations
← previousnext →

How this was built: Screen · Findings · About